Cross-Border Considerations for Privacy in Clinical Trials

Following the recent publication of DLA Piper’s Cross-border Guide to Clinical Trials and Privacy, James Clark, Paula Gonzalez de Castejón and David Kopans of DLA Piper discuss ongoing and developing EU and US perspectives on privacy considerations with respect to cross-border clinical trials.